We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

PharmaNet Development Group Demonstrates Comprehensive Capabilities at ASMS 2010

News   May 13, 2010

 
PharmaNet Development Group Demonstrates Comprehensive Capabilities at ASMS 2010
 
 
Advertisement
 

RELATED ARTICLES

Harmful Bisphenol Exposure of the Australian Population Estimated

News

By analyzing urine samples and wastewater, researchers report how human exposure to bisphenols, once common in food containers, receipts and electronics, has changed over time in an Australian population.

READ MORE

Expert Panel Makes Weak Recommendation for Use of Remdesivir To Treat Severe COVID-19

News

International experts have made a weak recommendation for the use of remdesivir in patients with severe COVID-19, advising continuation of patient enrolment for ongoing clinical trials of remdesivir to enable the collection of additional data.

READ MORE

Positive Results Reported for Phase 2 Study of Lyme Disease Vaccine Candidate

News

Positive initial results have been reported for the Phase 2 study of Lyme disease vaccine candidate VLA15.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE